Glenmark Pharmaceuticals shareholding pattern
GLENMARK
2317.9
15.00 (-0.64%)Last updated on 21 Aug, 2026 | 15:56 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Glenmark Pharmaceuticals Shareholding Pattern
- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
46.65%
Mutual Fund
17.86%
Insurance
1.03%
Foreign Institutional Investors
19.2%
Domestic Institutional Investors
1.24%
Retail
14.02%
Others
0%
Total Promoters
MAR '25
46.65%
JUN '25
46.65%
SEP '25
46.65%
DEC '25
46.65%
Summary
Glenmark Pharmaceuticals share holding pattern reports the following shareholding: Glenmark Pharmaceuticals Total Promoters is at 46.65%, Mutual Fund at 16.76%, Insurance at 1.02%, Foreign Institutional Investors at 20.89%, Domestic Institutional Investors at 0.86%, and Retail at 13.81%. This breakdown provides a quick snapshot of ownership distribution for Glenmark Pharmaceuticals share holding pattern in 2026-27.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals
Share Price - Glenmark Pharmaceuticals
Share Price chart - Glenmark Pharmaceuticals
Fundamental Analysis - Glenmark Pharmaceuticals
Technical Analysis - Glenmark Pharmaceuticals
Peer Comparison - Glenmark Pharmaceuticals
Share Price History - Glenmark Pharmaceuticals
Dividend - Glenmark Pharmaceuticals
Board of Directors
Glenmark Pharmaceuticals FAQs
As of 08-2026, the promoter shareholding in Glenmark Pharmaceuticals stands at 46.65% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Glenmark Pharmaceuticals is 20.89% and 0.86% respectively.
The retail shareholding of the Glenmark Pharmaceuticals is 13.81%.
Changes in shareholding patterns of Glenmark Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Glenmark Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLENMARK
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC